Origins of Lymphoma Unmasked

The first step on the path towards developing lymphoma happens in the blood cells when, at certain points in the chromosomes, breaks appear. It's a phenomenon known as a translocation, and the chromosomal fragments created by the break reassemble. No one can say why this occurs and no one knows how to prevent it from happening.

In the most recent issue of the journal Molecular Cell, researchers from the University of Southern California's Keck School of Medicine report that they have uncovered a key mechanism that leads to those breaks.

According to the authors, "The new findings go to the heart of why cancers begin. This is an opportunity to see the very beginning step of human lymphoma. With this information, we can now begin to look at ways to interfere with this process in order to stop the lymphoma and to develop more targeted therapies for treatment."

This study examined T cell lymphomas; back in December these same researchers took a similar look at B cell lymphomas.

For many years now, USC's Keck School of Medicine has been one of the leading research facilities in the search for what causes lymphomas and leukemias. This most recent study was funded by the National Institutes of Health.

For the record, the text of the published study, found HERE, qualifies for the most complex and unintelligible English language document I have ever examined.

Thank god for plain language press releases.

Source:
Noriko Shimazaki, Albert G. Tsai and Michael R. Lieber. "H3K4me3 Stimulates the V(D)J Rag Complex for Both Nicking and Hairpinning in trans in Addition to Tethering in cis: Implications for Translocations." Molecular Cell. June 12, 2009. DOI: 10.1016/j.molcel.2009.05.011.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap